Key takeaways

  • Mania, bipolar depression and relapse prevention need different evidence. A medicine useful in one phase may have a different role in another. NICE
  • Lithium needs blood levels and kidney, thyroid and calcium checks. Heat, sweating, dehydration, illness and interacting medicines can increase toxicity risk. NICE, HealthHub
  • Other medicines have distinct warning signs. Lamotrigine rash, antipsychotic metabolic or movement effects and valproate pregnancy restrictions need separate monitoring. HealthHub, NICE, HSA

Bipolar medicines require different monitoring

Bipolar Medicines Require Different Monitoring

Lithium, lamotrigine, valproate and antipsychotics may all appear in a bipolar treatment plan. “Mood stabiliser” does not mean they treat the same phase or need the same tests. Laboratory results, metabolic health, skin reactions, pregnancy and interactions affect selection. Abrupt stopping can trigger relapse, so the monitoring and stopping plans belong with the prescription.

Why does the phase of bipolar disorder matter?

Acute mania, bipolar depression and prevention of later episodes need different medicine choices. NICE lists haloperidol, olanzapine, quetiapine and risperidone as options when mania or hypomania develops in someone not already taking an antipsychotic or mood stabiliser. Past response, side effects, physical health, preferences and advance statements inform that choice. Recovery or residual symptoms between episodes also form part of the history. NICE

For example, lamotrigine may have a role in bipolar depression and maintenance but is not an acute antimanic medicine. Antipsychotics have medicine-specific roles across mania, depression or maintenance. Lithium has evidence across acute and long-term care but only works safely within a monitored exposure range. A catalogue cannot infer the phase from the diagnosis label.

NICE’s current bipolar-disorder recommendations organise treatment by phase and explicitly connect each medicine class to its own monitoring and stopping requirements.

How do the monitoring questions differ?

Blood levels, metabolic tests, skin symptoms and reproductive risks vary by medicine.

MedicineRole in specialist careMonitoring and warnings
LithiumMania and long-term relapse prevention in selected patientsBlood lithium level, kidney and thyroid function, calcium, hydration, interactions and toxicity symptoms
LamotrigineBipolar depression or maintenance in selected patientsSlow prescribed titration, new rash or mucosal symptoms, interactions and pregnancy-related level changes
Antipsychotics such as quetiapine or olanzapineMedicine-specific roles in mania, bipolar depression or maintenanceWeight, waist, blood pressure, glucose, lipids, sedation, movement and hormonal effects
Valproate/divalproexSelected acute or maintenance use under substantial reproductive-safety restrictionsPregnancy prevention, liver and blood effects, weight, interactions and medicine-specific safety controls

The same ingredient may also be used for epilepsy or another condition, with different treatment goals. Never assume that a friend’s dose, blood target or monitoring interval applies to bipolar treatment.

Why is lithium monitoring unusually visible?

Lithium has a narrow therapeutic range, so too little may be ineffective and too much can be toxic. NICE specifies blood levels 1 week after starting and after each dose change, then weekly until stable. It recommends checks every 3 months in the first year, then every 6 months, or still every 3 months in higher-risk groups such as older people, those with interacting medicines, poor control or adherence, organ-function risks or higher previous levels. Kidney function, thyroid, calcium and weight also need monitoring. NICE

Fluid and sodium balance affect lithium. Singapore heat, fever, heavy sweating, vomiting or diarrhoea can reduce fluid volume and raise risk. The current HealthHub lithium guide advises maintaining hydration and contacting a clinician during illnesses that cause heavy sweating, vomiting or diarrhoea.

HealthHub asks about plans to start a low-salt diet and warns that both too much and too little water can alter lithium exposure. It also says to inform the doctor before changing lithium brands and not to crush or chew a controlled-release tablet. HealthHub

Interactions matter. NSAID painkillers, some blood-pressure medicines and diuretics can alter lithium handling. Do not solve this by skipping lithium or another prescribed medicine independently; ask a clinician or pharmacist to check the exact products. Coarse tremor, worsening vomiting or diarrhoea, marked unsteadiness, confusion, severe drowsiness, blurred vision or muscle weakness can signal excessive lithium and need urgent advice.

What is different about lamotrigine?

Lamotrigine usually does not need routine blood levels during stable bipolar treatment, but early rash requires close attention. Rare severe skin reactions can occur. Dose escalation is deliberately gradual, and interrupted treatment may require a clinician to decide how it should be restarted rather than resuming the previous dose automatically.

HealthHub’s lamotrigine guide, reviewed 17 May 2024, asks for close rash monitoring during the first 3 months. It describes facial swelling and blisters in Stevens-Johnson syndrome (SJS). Toxic epidermal necrolysis (TEN) is more severe, with fever or flu-like symptoms and involvement of the mouth, eyes or genitals. The rash can spread within hours to days. New rash during titration needs immediate clinical advice, especially with peeling, blistering, sores, swelling, fever or feeling unwell.

Valproate can raise lamotrigine exposure, while some other medicines lower it. NICE CG185 recommendation 1.10.38 reserves lamotrigine levels for ineffectiveness, poor adherence or toxicity. For pregnancy, CG192 recommendation 1.4.32 asks for frequent checks before conception, during pregnancy and into the postnatal period because levels vary substantially. Arrange testing and adjustments with the treating team. NICE bipolar guidance, NICE perinatal guidance

What does antipsychotic monitoring add?

Antipsychotics need metabolic and physical checks as well as symptom review. Appetite, weight, glucose, lipids, sedation, blood pressure, movement and prolactin effects differ between medicines. Review sleep, alertness, restlessness, tremor, stiffness, menstrual or sexual changes and daily function alongside measurements and blood tests. See the fuller comparison of antipsychotic formulations and monitoring.

NICE specifies weekly weight or BMI for the first 6 weeks, then a check at 12 weeks. Fasting glucose or HbA1c and lipids are checked at 12 weeks; pulse and blood pressure after each dose change. The guidance keeps responsibility for efficacy and tolerability monitoring with the secondary-care team for at least 12 months, or until stable if that takes longer. Later transfer to primary care uses shared-care arrangements. NICE

An acceptable weight can coexist with abnormal glucose or lipids. Movement effects can be disabling despite normal laboratory results, so discuss symptoms and daily functioning at review too.

Why does valproate require a separate reproductive-safety discussion?

Valproate exposure in pregnancy carries high risks of malformations and developmental harm. Singapore’s HSA states that valproate is contraindicated during pregnancy for bipolar disorder and that use in women of childbearing potential is restricted by a pregnancy-prevention programme when alternatives are ineffective or not tolerated. See the HSA safety communication.

HSA’s 12 October 2018 communication gives approximately 10% for congenital malformations and up to 30-40% for serious developmental disorders among children exposed in utero. It describes a healthcare-professional guide, patient guide and patient card supporting the pregnancy-prevention measures. HSA

Pregnancy planning should prompt specialist review before conception, but valproate, lithium, lamotrigine or an antipsychotic should not be stopped abruptly without a coordinated plan. Untreated mania, depression or psychosis also carries serious risk, and the postnatal period can be a high-risk time for relapse.

What changes the answer?

Phase, past response, physical health, pregnancy and the treatment routine matter.

  • Current phase and past episodes. Mania, bipolar depression and maintenance require different evidence and urgency.
  • Previous benefit and adverse effects. A documented individual response may outweigh broad class comparisons.
  • Kidney, thyroid, liver and metabolic health. These change medicine suitability and monitoring intensity.
  • Pregnancy, contraception and breastfeeding. Risks are medicine-specific and need preconception planning where possible.
  • Heat, illness and interactions. Dehydration and interacting medicines are particularly important with lithium.
  • Adherence and formulation. Daily routine, modified-release tablets, missed doses and the ability to attend blood tests affect safety.

Which mood or safety changes need urgent help?

Inability to stay safe or a severe mood or physical change needs urgent assessment. Warning signs include suicidal intent, severe agitation or aggression, several nights with little or no sleep alongside escalating energy or risky behaviour, hallucinations, severe confusion or inability to care for basic needs. Suspected lithium toxicity, a severe lamotrigine rash, overdose, seizure or neuroleptic malignant syndrome also requires urgent care.

Bring the medicine list, blood results, recent dose or brand changes, missed doses and a short sleep/mood timeline to review. For immediate danger in Singapore, call 995. HealthHub MindSG lists 1771 for national mindline and 1767 for Samaritans of Singapore, both with 24-hour support; its national mindline chat number is 6669-1771. MindSG

The bipolar-disorder condition page explains medicine names for that discussion. A personal combination or stopping plan requires clinical review.

Sources